Roles of receptor activity‐modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Receptor activity‐modifying protein 1 (RAMP1) forms a complex with calcitonin receptor‐like receptor (CLR) to produce the receptor for calcitonin gene‐related peptide (CGRP). CGRP, a 37‐aa neuropeptide, is widely distributed in neuronal tissues and exerts its biological effects via CLR/RAMP1; however, the pathophysiological roles of CLR/RAMP1 remain to be clarified. To study the functions of CLR/RAMP1, we generated RAMP1‐knockout ( RAMP1 –/– ) mice. Compared with those of wild‐type (WT) mice, wound healing and wound‐induced angiogenesis were significantly suppressed in RAMP1 –/– mice, with reduced expression of vascular endothelial growth factor (VEGF)‐A. Formation of the lymphatic vessels that drain interstitial fluids was also suppressed in RAMP1 –/– mice, with reduced expression of VEGF‐C and VEGFR‐3 in wound granulation tissues. RAMP1 was expressed in endothelial cells (ECs) in the preexisting skin blood vessels, but was not observed in ECs in newly formed blood or lymphatic vessels. Macrophages in the wound granulation tissues expressed RAMP1 and produced substantial amounts of VEGF‐C in response to CGRP in vitro. RAMP1 –/– bone marrow chimeric mice showed delayed wound healing with reduced angiogenesis/lymphangiogenesis in wound granulation tissues. These findings suggest that RAMP1 plays a crucial role in wound healing and wound‐induced angiogenesis and lymphangiogenesis and that it is a promising target for controlling angiogenesis and lymphangiogenesis.—Kurashige, C., Hosono, K., Matsuda, H., Tsujikawa, K., Okamoto, H., Majima, M. Roles of receptor activity‐modifying protein 1 in angiogenesis and lymphangiogenesis during skin wound healing in mice. FASEB J. 28, 1237–1247 (2014). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The study found that wound healing and wound-induced angiogenesis were significantly suppressed in Ramp1 KO mice in comparison to WT controls.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [128]
In the citing paper
“Wound healing was also delayed in chimeric mice produced by transplantation of bone marrow from Ramp1 KO into WT mice, indicating a crucial role for hematopoietic cells recruited into the wound.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [128]
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Singer, A. J., & Clark, R. A. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411006 · Cited by 6,106
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134 · cited 1×
“CGRP binds to CGRP receptors composed of RAMP1 and calcitonin receptor-like receptor (CLR) to modulate various functions, such as vasodilation and pain transmission (2, 3).”
BackgroundAmara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. (1982) · Nature · doi:10.1038/298240a0 · Cited by 2,105
Adrenomedullin, a Multifunctional Regulatory Peptide*
Hinson, J. P., Kapas, S., & Smith, D. M. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0396 · Cited by 752 · cited 1×
“CLR is a common receptor subunit for both CGRP and adrenomedullin (AM), a 52-aa peptide that shares some degree of homology with CGRP (5).”
BackgroundMukouyama, Y.-S., Shin, D., Britsch, S., Taniguchi, M., & Anderson, D. J. (2002) · Cell · doi:10.1016/s0092-8674(02)00757-2 · Cited by 658 · cited 1×
“nerves result in arteries with misrouted axons (37).”
BackgroundPathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation
Baluk, P., Tammela, T., Ator, E., Lyubynska, N., Achen, M. G., Hicklin, D. J., Jeltsch, M., Petrova, T. V., Pytowski, B., Stacker, S. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522037 · Cited by 597
Molecular mechanisms of cancer pain
Mantyh, P. W., Clohisy, D. R., Koltzenburg, M., & Hunt, S. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc747 · Cited by 477
Vascular Growth Factors and Lymphangiogenesis
Jussila, L., & Alitalo, K. (2002) · Physiological Reviews · doi:10.1152/physrev.00005.2002 · Cited by 443
Axon Guidance Molecules in Vascular Patterning
Adams, R. H., & Eichmann, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001875 · Cited by 405 · cited 1×
“structure, the axonal growth cone (39).”
Kataru, R. P., Jung, K., Jang, C., Yang, H., Schwendener, R. A., Baik, J. E., Han, S. H., Alitalo, K., & Koh, G. Y. (2009) · Blood · doi:10.1182/blood-2008-09-176776 · Cited by 404
Molecular Biology and Pathology of Lymphangiogenesis
Karpanen, T., & Alitalo, K. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151515 · Cited by 356 · cited 1×
“The formation of lymphatic vessels, or lymphangiogenesis, occurs during the development of the corpus luteum and during wound healing and may be increased in certain pathologic processes (15).”
BackgroundHost Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth
Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021408 · Cited by 325
Self-citationAdrenomedullin, a Multifunctional Regulatory Peptide
Hinson, J. P. (2000) · Endocrine Reviews · doi:10.1210/er.21.2.138 · Cited by 256
The crucial role of macrophages in lymphangiogenesis
Kerjaschki, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26354 · Cited by 225
Dennis, T., Fournier, A., St Pierre, S., & Quirion, R. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20868-0 · Cited by 225 · cited 1×
“Using the peptidic antagonist CGRP (8–37) and the antagonist BIBN4096BS, pharmacologic researchers have classified CGRP receptors into 2 subtypes: CGRP-1 and CGRP-2 (21, 22).”
BackgroundCharacterization of CGRP1 and CGRP2 Receptor Subtypes a
QUIRION, R., VAN ROSSUM, D., DUMONT, Y., ST‐PIERRE, S., & FOURNIER, A. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb22759.x · Cited by 182 · cited 1×
“Using the peptidic antagonist CGRP (8–37) and the antagonist BIBN4096BS, pharmacologic researchers have classified CGRP receptors into 2 subtypes: CGRP-1 and CGRP-2 (21, 22).”
BackgroundBell, D., & McDermott, B. J. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06943-1 · Cited by 175
Toda, M., Suzuki, T., Hosono, K., Hayashi, I., Hashiba, S., Onuma, Y., Amano, H., Kurihara, Y., Kurihara, H., Okamoto, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800767105 · Cited by 140 · cited 1×
“Recently, we found that CGRP also exhibits proangiogenic activity in models of cancer and hindlimb ischemia (11, 12).”
BackgroundSelf-citationTsujikawa, K., Yayama, K., Hayashi, T., Matsushita, H., Yamaguchi, T., Shigeno, T., Ogitani, Y., Hirayama, M., Kato, T., Fukada, S.-I., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705974104 · Cited by 136 · cited 2×
“RAMP1 / mice were developed as described elsewhere (7).”
BackgroundSelf-citationRoles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis
Toda, M., Suzuki, T., Hosono, K., Kurihara, Y., Kurihara, H., Hayashi, I., Kitasato, H., Hoka, S., & Majima, M. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.02.003 · Cited by 130
Self-citationLangenkamp, E., & Molema, G. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0642-4 · Cited by 119 · cited 1×
“It has been frequently reported that microvascular ECs display a large degree of functional heterogeneity, depending on their location in the vascular tree (25).”
BackgroundCalcitonin gene-related peptide and hypertension
Deng, P.-Y., & Li, Y. (2005) · Peptides · doi:10.1016/j.peptides.2005.02.002 · Cited by 117 · cited 1×
“CGRP binds to CGRP receptors composed of RAMP1 and calcitonin receptor-like receptor (CLR) to modulate various functions, such as vasodilation and pain transmission (2, 3).”
BackgroundCalcitonin gene-related peptide: Vasoactive effects and potential therapeutic role
Brain, S. D., & Cambridge, H. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00125-5 · Cited by 106
Ohno, T., Hattori, Y., Komine, R., Ae, T., Mizuguchi, S., Arai, K., Saeki, T., Suzuki, T., Hosono, K., Hayashi, I., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.001 · Cited by 95 · cited 2×
“tissues (13), and recovery from hindlimb ischemia”
BackgroundSelf-citationHay, D. L., Poyner, D. R., & Quirion, R. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00372 · Cited by 86 · cited 1×
“Although more CGRP receptor subtypes have been suggested, only one receptor, CLR, which belongs to a large family of GPCRs, has been identified molecularly (23).”
BackgroundRAMPs: 5 years on, where to now?
Morfis, M. M., Christopoulos, A., & Sexton, P. M. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.001 · Cited by 82 · cited 1×
“The RAMP protein family consists of 3 members, RAMP1, RAMP2, and RAMP3, each of which is encoded by a separate gene and has diverse spatiotemporal expression patterns (1).”
BackgroundArchbold, J. K., Flanagan, J. U., Watkins, H. A., Gingell, J. J., & Hay, D. L. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.007 · Cited by 80
Calcitonin gene-related peptide promotes angiogenesis via AMP-activated protein kinase
Zheng, S., Li, W., Xu, M., Bai, X., Zhou, Z., Han, J., Shyy, J. Y.-J., & Wang, X. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00173.2010 · Cited by 78 · cited 1×
“3C, D), consistent with a previous in vitro report (34).”
BackgroundCalcitonin Gene-Related Peptide and Regulation of Human Cardiovascular Homeostasis
Preibisz, J. (1993) · American Journal of Hypertension · doi:10.1093/ajh/6.5.434 · Cited by 72
Calcitonin gene-related peptide facilitates revascularization during hindlimb ischemia in mice
Mishima, T., Ito, Y., Hosono, K., Tamura, Y., Uchida, Y., Hirata, M., Suzsuki, T., Amano, H., Kato, S., Kurihara, Y., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00466.2010 · Cited by 69 · cited 1×
“Recently, we found that CGRP also exhibits proangiogenic activity in models of cancer and hindlimb ischemia (11, 12).”
BackgroundSelf-citationAmano, H., Ando, K., Minamida, S., Hayashi, I., Ogino, M., Yamashina, S., Yoshimura, H., & Majima, M. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.87.181 · Cited by 68 · cited 1×
“angiogenesis in a sponge implantation model (33).”
Self-citationBoku, K., Ohno, T., Saeki, T., Hayashi, H., Hayashi, I., Katori, M., Murata, T., Narumiya, S., Saigenji, K., & Majima, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.20916 · Cited by 67
Self-citationMolecular Mechanisms of Cancer
Weber, G. F. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6016-8 · Cited by 62
Steiner, S., Muff, R., Gujer, R., Fischer, J. A., & Born, W. (2002) · Biochemistry · doi:10.1021/bi020279r · Cited by 60 · cited 1×
“The specificity of the CGRP receptor is believed to be decided by RAMP1, in light of the finding that the N terminus of RAMP1 is essential for CGRP binding (6).”
BackgroundKamoshita, E., Ikeda, Y., Fujita, M., Amano, H., Oikawa, A., Suzuki, T., Ogawa, Y., Yamashina, S., Azuma, S., Narumiya, S., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051358 · Cited by 56 · cited 2×
“Surgical wounds were made on the backs of the mice, as described elsewhere (19).”
BackgroundMethodSelf-citationArai, K., Ohno, T., Saeki, T., Mizuguchi, S., Kamata, K., Hayashi, I., Saigenji, K., Murata, T., Narumiya, S., & Majima, M. (2003) · Gut · doi:10.1136/gut.52.9.1242 · Cited by 36
Notch signalling in ischaemia-induced angiogenesis
Zen, A. A. H., & Madeddu, P. R. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371221 · Cited by 33 · cited 1×
“Activation of the Notch pathway and VEGF signaling induces angiogenic growth of ECs and the selection of tip cells, and Notch signaling is a key pathway that is activated during ischemiainduced neovascularization (40).”
BackgroundSaeki, T., Ohno, T., Boku, K., Saigenji, K., Katori, M., & Majima, M. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.014s1135.x · Cited by 29
Self-citationDunworth, W. P., & Caron, K. M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.185066 · Cited by 29 · cited 1×
“(28), and the presence of the AM receptor on lym-”
BackgroundUnderstanding RAMPs Through Genetically Engineered Mouse Models
Kadmiel, M., Fritz-Six, K. L., & Caron, K. M. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-2364-5_5 · Cited by 24 · cited 1×
“Several gene-targeted knockout and transgenic models have been generated and characterized in recent years (4).”
BackgroundNerves Tell Arteries to Make Like a Tree
Miller, G. L. (2002) · Science · doi:10.1126/science.296.5576.2121a · Cited by 24
Clinical Pharmacology of Vasodilator Peptides
Brown, M. J., & Morice, A. (1986) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198609002-00010 · Cited by 16
Clinical Pharmacology of Vasodilator Peptides
Brown, M. J., & Morice, A. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198710012-00011 · Cited by 15
Cited by
Cellular and molecular mechanisms of skin wound healing
Peña, O. A., & Martin, P. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00715-1 · Cited by 1,655
“…that might mediate lymphangiogenesis have been reported, including prostaglandin E 2 receptors EP3 and EP4 and receptor activity-modifying protein 1 (RAMP1) 164,165 , but the most convincing mediators of lymphatic vessel sprouting are VEGF receptor 3 (VEGFR3) and its ligands VEGFC and VEGFD.”
Nociceptor Sensory Neuron–Immune Interactions in Pain and Inflammation
Pinho-Ribeiro, F. A., Verri, W. A., & Chiu, I. M. (2017) · Trends in Immunology · doi:10.1016/j.it.2016.10.001 · Cited by 1,027
“The CGRP receptor RAMP1 is necessary for proper angiogenesis and lymphangiogenesis during skin wound healing, and regulates VEGF production [71].”
Neuronal regulation of immunity: why, how and where?
Schiller, M., Ben-Shaanan, T. L., & Rolls, A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-0387-1 · Cited by 264
Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles
Hay, D. L., & Pioszak, A. A. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103120 · Cited by 190
In vivo reprogramming of wound-resident cells generates skin epithelial tissue
Kurita, M., Araoka, T., Hishida, T., O’Keefe, D. D., Takahashi, Y., Sakamoto, A., Sakurai, M., Suzuki, K., Wu, J., Yamamoto, M., et al. (2018) · Nature · doi:10.1038/s41586-018-0477-4 · Cited by 148
Metadata
- Authors
- Kurashige, C., Hosono, K., Matsuda, H., Tsujikawa, K., Okamoto, H., & Majima, M.
- Affiliations
- Kitasato University Hospital (JP)
- Kitasato University (JP)
- The University of Osaka (JP)
- Corresponding author
- Majima, Masataka
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-12-05
- Volume
- 28
- Issue
- 3
- Pages
- 1237-1247
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2156179708
- Semantic Scholar
- 83ea945b1fa6d510c894123338adf424d5700576
- Cited by
- 67
- References
- 44
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 10 · 2023: 3 · 2022: 9 · 2021: 4 · 2020: 11 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 4 · 2015: 2 · 2014: 1
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (22116001, 25860192, 24659119)
- Topics
- Health Sciences › Medicine › Surgery › Wound Healing and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- RAMP1, calcitonin receptor-like receptor, calcitonin gene-related peptide, angiogenesis, lymphangiogenesis, skin wound healing, VEGF-A, VEGF-C, VEGFR-3, macrophages, endothelial cells, bone marrow chimeras
- MeSH terms
- Animals, Base Sequence, Skin, Wound Healing, DNA Primers, Neovascularization, Physiologic, Lymphangiogenesis, Mice, Receptor Activity-Modifying Protein 1, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.